PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) Fair Value & Analysis
Consumer Defensive · ID · Market cap 11.2T IDR
Fair value as of: Jul 11, 2026
From 26 valuation models · updated 29 days ago
Share price −5.9% over the past month.
A strong business, screening 111% undervalued on our models.
What matters now
- The rarer combination: high quality (91/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (493.31 IDR). The market is more pessimistic than our downside scenario.
- A fairly wide model range (493.31 IDR to 986.35 IDR) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.
How to read this chart
60‑month range 352.00 IDR – 808.04 IDR · fair‑value band 493.31 IDR – 986.35 IDR · the 352.00 IDR price screens below the 742.91 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 11, 2026.
Analysis
PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) currently trades at 352.00 IDR, while our model-based Fair Value estimate is 742.91 IDR, implying the stock looks roughly 111.1% undervalued today. The Quality Score stands at 91/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, PT Industri Jamu dan Farmasi Sido Muncul Tbk generated revenue of 3.9T IDR at a net margin of 29.1%. Revenue declined 18.8% year over year. It earns a return on equity of 32.8%. The balance sheet holds a net cash position of 458B IDR. Fundamentals as of Jul 11, 2026
Our scenario range runs from 493.31 IDR (bear case) to 986.35 IDR (bull case); at 352.00 IDR, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 36% below its 52-week high and 1% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 111%, SIDO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (761.66 IDR) versus Asset-Based (71.03 IDR). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 87 · Market factors (momentum, volatility) 32
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through three segments: Herbal Medicine and Supplements; Food and Beverage; and Pharmacy.
Full company description
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through three segments: Herbal Medicine and Supplements; Food and Beverage; and Pharmacy. It also offers medicine products comprising ethical/prescriptions and OTCs; herbal products, such as traditional herbals, food and beverages, herbal medicines, supplements, vitamins, and mom, kids, and baby products; and powder and liquid herbal ingredients for ache and pain relief, antibiotics, anemia, anti-allergy, antioxidants, blood pressure, brain function, bone health, children's health, cold, flu, and cough, diabetes, digestion, energy and vitality, heart and cholesterol, immune system, joints and mobility, liver and detox, men's and skin health, sleep aids, tumor and cancer, weight management, women's health, and others. In addition, it is involved in commerce, land transportation, wastewater treatment, and plantation and printing activities. The company was founded in 1940 and is headquartered in Semarang, Indonesia. PT Industri Jamu dan Farmasi Sido Muncul Tbk is a subsidiary of PT Hotel Candi Baru.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PT Industri Jamu dan Farmasi Sido Muncul Tbk reported revenue of 4.1T IDR in FY2025 versus 4.0T IDR in FY2021, a compound +0.4%/yr. Reported net income was 1.2T IDR in FY2025, compounding −0.6%/yr from FY2021.
Watch SIDO: get an alert when its fair value changes →
Peer Group
Packaged Foods · 653 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare PT Industri Jamu dan Farmasi Sido Muncul Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) overvalued or undervalued?
What is the fair value of SIDO?
What is the quality score of SIDO?
What is the revenue of PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO)?
What is the net profit margin of SIDO?
Does PT Industri Jamu dan Farmasi Sido Muncul Tbk pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Industri Jamu dan Farmasi Sido Muncul Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.